Evolving role of HER2/ERBB2 targeting in CRC: 2026 Updates: Dr. Raghav (2026)
In this COLONTOWN DocTalk, Dr. Kanwal Raghav from MD Anderson talks about HER2/ERBB2 targeted therapies for metastatic colorectal cancer with HER2/ERBB2 amplification. For other HER2 and biomarker-specific Doctalks visit the COLONTOWN University Lecture Hall https://learn.colontown.org/learningc...
▶︎
Emerging Bispecific Antibody Treatment Strategies in Advanced Colorectal Cancer: Dr. DeVito (2026)
▶︎
Primary Biliary Cholangitis (PBC) and Primary Sclerosing Cholangitis (PSC) webinar
▶︎
RASolute-302 with Daraxonrasib - Game Changer at ASCO 2026 in Pancreatic Cancer
▶︎
Prof Graeme Meintjes - Revive trial seminar 2026
▶︎
The World's Most Important Machine
▶︎
Female-Specific Exercise & Nutrition for Health, Performance & Longevity | Dr. Stacy Sims
▶︎
Meet the Former CIA Agent Who Wants to Abolish the CIA
▶︎
But what is quantum computing? (Grover's Algorithm)
▶︎
BREAKING NEWS: COVID-19 Whistleblower Testifies Publicly Before Rand Paul-Led Senate Committee
▶︎
AFIB Questions with Sandy Schrameyer (Dr. Randall Wolf)
▶︎
Beyond EGFR TKIs in the Management of Advanced or Metastatic EGFRm NSCLC
▶︎
What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
▶︎
How to Speak Clearly & With Confidence | Matt Abrahams
▶︎
Jack Smith & Brian Driscoll On Weaponizing Justice | The Weekly Show with Jon Stewart
▶︎
CRC Updates from ESMO25: Dr. Hornstein (2025)
▶︎
Violence Expert: Real Self-Defense Is TERRIFYING
▶︎
Colorectal Cancer and Immunotherapy with Dr. Van Morris
▶︎
Think Fast, Talk Smart: Communication Techniques
▶︎
Why You Can’t Sleep (and How to Fix It) | Dr. Michael Grandner
▶︎